Higher dietary potassium intake is associated with lower blood pressure, better kidney outcomes and improved survival. However, the risk of hyperkalemia limits implementation of healthy potassium-rich diets in patients with chronic kidney disease(CKD). Novel potassium binders such as sodium zirconium cyclosilicate(SZC) may enable a more liberal intake of potassium-rich diets and thereby enable their cardiorenal benefits.